Welcome to our dedicated page for Avanos Medical news (Ticker: AVNS), a resource for investors and traders seeking the latest updates and insights on Avanos Medical stock.
Avanos Medical, Inc. (NYSE: AVNS) is a leading medical technology company based in Alpharetta, Georgia. Specializing in breakthrough solutions, Avanos focuses on helping patients recover from surgery and move back to their normal lives while minimizing opioid use.
The company offers innovative medical devices and services in over 90 countries, addressing critical healthcare needs. Avanos' key areas of operation include Digestive Health and Pain Management and Recovery. Recently, they've integrated their Chronic Care and Pain Management franchises into a single commercial entity. This restructuring has enabled Avanos to enhance its focus on digestive health and non-opioid pain relief solutions.
Avanos made headlines with its acquisition of Diros Technology Inc., a leader in radiofrequency (RF) ablation technology for chronic pain management. Diros' RF Trident™ technology, known for delivering precise, minimally invasive pain treatment, complements Avanos' COOLIEF* Cooled Radiofrequency offerings. This acquisition is expected to broaden Avanos' market reach and enhance its portfolio of non-opioid pain management products.
In 2023, Avanos reported steady financial growth, with notable performance in its Digestive Health sector. Despite a slight overall sales decline, the company's operational focus and strategic acquisitions have positioned it well for future growth. Avanos continues its three-year transformation initiative, emphasizing optimized commercial operations, product portfolio transformation, cost management, and strategic M&A activity.
Moreover, Avanos recently aligned with the UK's National Institute for Health and Care Excellence (NICE) guidelines, supporting the use of RF ablation for osteoarthritic knee pain—an endorsement that could spur similar guidelines globally.
However, Avanos faced challenges, including a voluntary recall of certain gastric-jejunal feeding tube kits due to sterility concerns related to pre-filled syringes. Despite these hurdles, the company remains resolute in its commitment to delivering superior healthcare solutions.
For more information, visit www.avanos.com and follow Avanos Medical on Twitter, LinkedIn, and Facebook.
FAQ
What is the current stock price of Avanos Medical (AVNS)?
What is the market cap of Avanos Medical (AVNS)?
What does Avanos Medical specialize in?
Where is Avanos Medical headquartered?
What was a significant recent acquisition by Avanos Medical?
What are Avanos Medical's primary product categories?
How is Avanos Medical contributing to non-opioid pain management?
What recent endorsement did Avanos receive from NICE?
What is the focus of Avanos Medical's three-year transformation initiative?
How does Avanos Medical market its products?
What was one of the recent challenges faced by Avanos Medical?
Where can I find more information about Avanos Medical?
